RAGE is a potential biomarker implicated in immune infiltrates and cellular senescence in lung adenocarcinoma

Background Receptor for Advanced Glycation End‐products (RAGE) is an oncogene abnormally expressed in various cancers. However, the clinical value of RAGE and the biological role of RAGE in lung cancer have not been fully investigated. Methods We compared the RAGE expression using several public dat...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical laboratory analysis Vol. 36; no. 5; pp. e24382 - n/a
Main Authors Lin, Zhihui, Yu, Biyun, Yuan, Li, Tu, Jinjing, Shao, Chuan, Tang, Yaodong
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.05.2022
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Receptor for Advanced Glycation End‐products (RAGE) is an oncogene abnormally expressed in various cancers. However, the clinical value of RAGE and the biological role of RAGE in lung cancer have not been fully investigated. Methods We compared the RAGE expression using several public databases. The relationship between RAGE expression and clinicopathological variables was assessed. The R software package was used to carry out enrichment analyses of RAGE co‐expression and gene set enrichment analysis (GSEA). Additionally, we used the TIMER database to assess the association between immune infiltration and RAGE expression. The correlation between RAGE expression and senescence biomarkers in lung adenocarcinoma was analyzed using the TCGA database. Results Our findings indicated that the expression of RAGE was downregulated in lung adenocarcinoma, and down‐regulation of RAGE was related to poor overall survival and disease‐free survival. Functional enrichment analysis indicated that RAGE co‐expression genes were mainly associated with neutrophil activation involved in immune response, neutrophil degranulation, and regulation of leukocyte‐mediated immunity. Correlation analysis revealed that RAGE expression was closely related to the purity of the tumor and immune infiltration. GSEA indicated that the RAGE‐related differential genes were mainly enriched in senescence‐related pathways. Besides, the RAGE expression was significantly associated with senescence‐related genes. Conclusion Down‐regulation of RAGE expression was associated with poor prognosis, as well as defective immune infiltration and cellular senescence in lung adenocarcinoma. We compared the AGER expression using several public databases. The relationship between AGER expression and clinicopathological variables was assessed. R software package was used to carry out enrichment analyses of AGER co‐expression and gene set enrichment analysis (GSEA). Additionally, we used TIMER database to assess the association between immune infiltration and AGER expression. The correlation between AGER expression and senescence biomarkers in lung adenocarcinoma was analyzed using TCGA database.
Bibliography:Funding information
This research was supported by the Ningbo Clinical Research Center for thoracic & breast neoplasms (2021L002) and the major science and technology innovation in 2025 projects of Ningbo (2019B10039)
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0887-8013
1098-2825
DOI:10.1002/jcla.24382